Result: Endpoints: Technical success 57 (100%), survival: 54 (94.7%), target vessel patency: 55 (96.5%), re - intervention 0 (0%), 30-day in-hospital mortality: 3 (5.3%), endoleak: 2 (3.5%), spinal cord ischemia: 2 (3.5%); stroke: 1 (1.8%), infective: 1 (1.8%).